Tark S. Patel

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A metabolite extracted from Escherichia coli suppresses tau aggregation.

A metabolite extracted from Escherichia coli suppresses tau aggregation.

Journal: The Biochemical journal

Published: January 28, 2026

A metabolite extracted from E. coli suppresses tau aggregation.

A metabolite extracted from E. coli suppresses tau aggregation.

Journal: The Biochemical journal

Published: January 28, 2026

DAP12 deletion reduces neuronal SLIT2 and demyelination and enhances brain resilience in female tauopathy mice.

DAP12 deletion reduces neuronal SLIT2 and demyelination and enhances brain resilience in female tauopathy mice.

Journal: Molecular neurodegeneration

Published: June 14, 2025

APOE3-R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition.

APOE3-R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition.

Journal: bioRxiv : the preprint server for biology

Published: May 07, 2024

The R136S mutation in the APOE3 gene confers resilience against tau pathology via inhibition of the cGAS-STING-IFN pathway.

The R136S mutation in the APOE3 gene confers resilience against tau pathology via inhibition of the cGAS-STING-IFN pathway.

Journal: Immunity

Published: April 10, 2024

Disease-Associated Mutations in Tau Encode for Changes in Aggregate Structure Conformation.

Disease-Associated Mutations in Tau Encode for Changes in Aggregate Structure Conformation.

Journal: ACS chemical neuroscience

Published: December 06, 2023

DAP12 deficiency alters microglia-oligodendrocyte communication and enhances resilience against tau toxicity.

DAP12 deficiency alters microglia-oligodendrocyte communication and enhances resilience against tau toxicity.

Journal: bioRxiv : the preprint server for biology

Published: November 14, 2023

Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.

Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.

Journal: bioRxiv : the preprint server for biology

Published: September 25, 2023

Native PLGA nanoparticles attenuate Aβ-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer's disease pathology.

Native PLGA nanoparticles attenuate Aβ-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer's disease pathology.

Journal: Scientific reports

Published: August 29, 2023

Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.

Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.

Journal: Cell

Published: June 10, 2023

Streamlined high-throughput cloning protocol to generate arrayed mutant libraries.

Streamlined high-throughput cloning protocol to generate arrayed mutant libraries.

Journal: STAR protocols

Published: September 12, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026